Actually, How Wrong Was Geert Vanden Boschee in March of 2021?
Time to factcheck the factcheckers.
It’s fun to have a hindsight 20/20 advantage, isn’t it? Back in March of 2021, the factchekers were foaming at the mouth, denouncing Geert Vanden Boschee for his warning against massive jabbing campaign into the pandemic:
Here’s a sample of just two more measured pseudo-scientific counter-essays from back then:
“The Doomsday Prophecy of Dr. Geert Vanden Bossche” (McGill Office for Science and Society, Separating Sense from Nonsense, March 21, 2021):
Many vaccines prevent transmission of the virus from person to person, and there is mounting evidence that the COVID-19 vaccines do as well. Even if they don’t prevent all transmissions, it looks like they can drastically cut the transmission chain.
Even if the COVID-19 vaccines were “leaky,” meaning they still allowed some vaccinated people to transmit the virus to others, there is evidence that they could still efficiently contain the spread of the disease. Edward Nirenberg, a science blogger who addressed Dr. Bossche’s claims in great detail, points to Marek’s disease [poultry virus causing cancer in birds]. ..Newer and more virulent strains of the virus have been detected. The use of this seemingly leaky vaccine in chickens led to a reduction in the incidence of Marek’s disease by 99%. Potentially leaky vaccine but stellar disease reduction.
If a new SARS-CoV-2 variant emerges and is so different that our current crop of vaccines don’t match it, scientists can simply tweak their vaccines.
Dr. Bossche’s concern about imperfect vaccines allowing the virus to mutate should be dwarfed by the much larger, evidence-based worry of allowing the virus to mutate inside of unvaccinated people.
Dr. Bossche seems to be a big fan of the innate immune system and he worries that all of these COVID-19 vaccines and public health measures are getting in the way of our innate immune system fighting off the coronavirus.
“Addressing Geert Vanden Bossche’s Claims” (Edward Nierenberg, March 15, 2021):
GVB: “It's not exactly rocket science, it’s a basic principle taught in a student’s first vaccinology class: One shouldn’t use a prophylactic vaccine in populations exposed to high infectious pressure (which is now certainly the case as multiple highly infectious variants are currently circulating in many parts of the world).” EN: “There is no such principle. It in fact directly goes against current policies for responding to outbreaks of e.g. measles, mumps, meningococcal disease, etc. and more generally is directly at odds with the incredibly effective ring vaccination strategy. “
GVB: “To fully escape selective immune pressure exerted by vaccinal antibodies, Covid-19, a highly mutable virus, only needs to add another few mutations in its receptor-binding domain”. EN: “The antibody titers induced by the vaccines are MUCH higher than those seen with infection, and we see hallmarks of memory responses induced by these vaccines from even a single dose, meaning that even though there is a drop in neutralization, it may not mean a loss in protection.”
And so on, and so forth, Nierenberg spewing innuendos, misrepresentations and hate. Read the linked article for the full load.
Let’s now take stock of just some select evidence in support of GVB that has arrived since then.
“Are Vaccines Fueling New Covid Variants? The virus appears to be evolving in ways that evade immunity” (WSJ, 2023.01.01):
Public-health experts are sounding the alarm about a new Omicron variant dubbed XBB that is rapidly spreading across the Northeast U.S. Some studies suggest it is as different from the original Covid strain from Wuhan as the 2003 SARS virus. Should Americans be worried?
It isn’t clear that XBB is any more lethal than other variants, but its mutations enable it to evade antibodies from prior infection [???] and vaccines as well as existing monoclonal antibody treatments. Growing evidence also suggests that repeated vaccinations may make people more susceptible to XBB and could be fueling the virus’s rapid evolution.
Omicron has begotten numerous descendents, many of which have popped up in different regions of the world curiously bearing some of the same mutations.
“Such rapid and simultaneous emergence of multiple variants with enormous growth advantages is unprecedented,” a Dec. 19 study in the journal Nature notes. Under selective evolutionary pressures, the virus appears to have developed mutations that enable it to transmit more easily and escape antibodies elicited by vaccines and prior infection.
Oh, really? And what did you expect, jabbing into the pandemic with non-neutralizing jabs? Here goes their Marek’s disease argument, and, basically, all other retorts to GVB. When they say “prior infection”, they are too modest to admit that they are speaking about “breakthrough” infections post their jabs. We already knew that, by the time Omicron was around, the boosted reinfected carried the cultureable virus longer than simply jabbed or the unvaccinated — “Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection” (NEJM, 2022.06.29):
At five days post-infection, less than 25 percent of unvaccinated people were still contagious, whereas around 70 percent of boosted people were still carrying viable virus particles. For those partially vaccinated, around 50 percent were still contagious at this point.
Even more strikingly, at ten days post-infection, one-third of boosted people (31 percent) were found to still be carrying live, culturable virus. By contrast, just six percent of unvaccinated people were still contagious at day 10.
In other words, people who have received a booster shot are five times more likely still to be contagious at ten days post-infection than are unvaccinated people.
And as if this wasn’t enough, here’s the greatest-latest fiasco of the mRNA treatments - “Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination” (Science Immunology, 2022.12.22):
…IgG4 is considered as an anti-inflammatory IgG with low potential to mediate Fc-dependent effector function such as ADCC or ADCP (20, 45).
High levels of antigen-specific IgG4 have been reported to correlate with successful allergen-specific immunotherapy by blocking IgE-mediated effects (46). In addition, increasing levels of bee venom-specific IgG4 have been detected in beekeepers over several beekeeping seasons and finally even became the dominant IgG subclass for the specific antigen, i.e. phospholipase A (PLA).
So far, only few studies on the role of vaccine-induced IgG4 responses against infectious diseases are available. In the field of HIV vaccine development, repeated protein immunization in the trial VAX003 (49) led to higher levels of HIV gp120-specific IgG2 and IgG4, whereas a prime-boost immunization with a canarypox vector (ALVAC) and the same protein vaccine in the RV144 trial (50) resulted in higher HIV-specific IgG3 responses correlating with partial protection against HIV (51, 52). Furthermore, the vaccine-elicited IgG3 antibodies enhanced effector functions as ADCC and ADCP, but vaccine-induced IgG4 inhibited those functions (52).
In our study, antibody-mediated phagocytic activity and complement deposition were reduced in sera after the third immunization, in parallel to higher proportions of anti-spike IgG4 antibodies. …our results clearly demonstrate that a subsequent infection can further boost IgG4 antibody levels, with IgG4 becoming the most dominant among all anti-spike IgG subclasses in some individuals.
So, the jabbed-boosted-reinfected develop permanent immune tolerance to the Covid virus variants, let alone some waning imperfect immunity, that makes them catch the virus on a continuous basis and keep reinfecting everyone around.
All of the above on top of the already well-documented actual negative protection of the jabs in relativey short time after the jabs — “Elevated risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variant compared to Alpha variant in vaccinated individuals” (Science, 2022.07.21):
We found evidence of an increased risk of infection by the Beta (B.1.351), Gamma (P.1), or Delta (B.1.617.2) variants compared to the Alpha (B.1.1.7) variant after vaccination. No clear differences were found between vaccines. However, the effect was larger in the first 14-59 days after complete vaccination compared to ≥60 days. In contrast to vaccine-induced immunity, there was no increased risk for re-infection with Beta, Gamma or Delta variants relative to Alpha variant in individuals with infection-induced immunity.
Thus, the trade-off between the upfront milder course of disease absent proper treatment and the gained natural immunity to easily treatable virus is the long-term doom-and-gloom of an inevitable death sentence at the hands of the future mutated viruses that keep coming at an accelerated clip. No amount of testing or masking will ever fix that. The boosted are doomed, in a very immediate way. As GVB bemoaned since the beginning of this JabOp. I rest my case.
Please allocate multiples of the duration of the video below to upgrade your understanding by listening to GVB discuss this topic in depth a few times, as much of it has not been expounded so well anywhere else:
"It will be a dark winter of death for those who don't get boosted." The truth is always the opposite of what they tell us.
GVB was the person who convinced me the “shot” campaign was A money trail. His words “you cannot vaccinate your way out of a pandemic” stuck with me. Plus, he was employed inside Bill Gates vaccine research at one time.